Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myeloma

Annals of Hematology

Volumn 78, Issue 10, 1999, Pages 456-462

  Kobbe, G ^a   Sohngen D ^a   Bauser, U ^a   Schneider, P ^a   Germing, U ^a   Thiele, K P ^a   Rieth, C ^a   Hunerliturkoglu A ^a   Fischer, J ^a   Frick, M ^a   Wernet, P ^a   Aul, C ^a   Heyll, A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

CD34+ cells; G CSF; Malignant lymphoma; Multiple myeloma; PBPC mobilization

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PARACETAMOL; PREDNISONE; VINCRISTINE;

ARTICLE; ASSAY; AUTOGRAFT; BONE PAIN; CELL MOTILITY; CRYOPRESERVATION; FLOW CYTOMETRY; HEADACHE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; LYMPHOMA; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; ANTIGENS, CD34; CYTOTOXINS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PREDICTIVE VALUE OF TESTS; TIME FACTORS;

EID: 0345425798     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050598     Document Type: Article

References (25)

1. Appelbaum FR, Sullivan KM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Hill R, Mortimer J, Neiman PE, Sanders JE (1987) Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation and marrow transplantation. J Clin Oncol 5:1340-1347
2. Barlogie B, Alexanian R, Smallwood L, Cheson B, Dixon D, Dicke K, Cabanillas F (1988) Prognostic factors with high-dose melphalan for refractory multiple myeloma. Blood 72:2015-2019
3. Prince HM, Imrie K, Crump M, Stewart AK, Girouard C, Colwill R, Brandwein J, Tsang RW, Scott JG, Sutton DMC, Pantalony D, Carstairs K, Sutcliffe SB, Keating A (1996) The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups. Br J Haematol 92:880-889
4. Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF, Casassus P, Maisonneuve H, Faccon T, Ifrah N, Payen C, Bataille R for the Intergroupe Francais du Myelome (1996) A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 335:91-97
5. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts NM, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K (1996) Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:353-357
6. To LB, Haylock D, Dyson P, Simmons P Juttner C (1996) Chemotherapy based approaches to mobilization of progenitor cells. In: Morstyn G, Sheridan W (eds) Cell therapy. Cambridge University Press, New York, pp 130-145
7. Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D (1988) Effects of recombinant granulocyte colony-stimulating factor on hemopoietic progenitor cells in cancer patients. Blood 72:2074-2081
8. Kobbe G, Soehngen D, Heyll A, Fischer J, Thiele KP, Aul C, Wernet P (1997) Large-volume leukapheresis maximizes the progenitor cell yield for allogeneic peripheral blood progenitor donation. J Hematother 6:125-131
9. Körbling M, Fliedner TM (1996) The evolution of clinical peripheral blood stem cell transplantation. Bone Marrow Transplant 17:675-678
10. Desikan KR, Barlogie B, Jagannath S, Vesole DH, Siegel D, Fassas A, Munshi N, Singhal S, Metha J, Tindle S, Nelson J, Bracy D, Mattox S, Tricot G (1998) Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. J Clin Oncol 16:1547-1553
11. Kröger N, Zeller W, Hassan HT, Krüger W, Renges H, Hummel K, Gutensohn K, Lölliger C, Zander AR (1998) Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone. Ann Hematol 76:257-262
12. Weaver CH, Schwartzberg LS, Birch R, Greco FA, Rhinehart S, Hainsworth J, Beeker T, Price H, Geier L, Foster J, West J, Hazelton B, Buckner CD (1997) Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients. Transfusion 37:896-703
13. Goldschmidt H, Hegenbart U, Wallmeier M, Hohaus S, Haas R (1997) Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma. Br J Haematol 98:736-744
14. Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger WI (1996) Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 17:937-941
15. Trainor KJ, Morley AA (1976) Screening of cytotoxic drugs for residual bone marrow damage. J Natl Cancer Inst 57:1237-1239
16. Drake M, Ranaghan L, Morris TCM, Nolan L, Desai ZR, Irvine AE, Jordan A, Magill K, Price S (1997) Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 98:745-749
17. Dreger P, Haferlach T, Eckstein V, Jackobs S, Suttorb M, Löffler H, Müller-Ruchholz W, Schmitz N (1994) G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization and composition of the graft. Br J Haematol 87:609-613
18. Zeller W, Gutensohn K, Stockschläder M, Dierlamm J, Kröger N, Koehne G, Hummel K, Kabisch H, Weh HJ, Kühnl P, Hossfeld DK, Zander AR (1996) Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis. Bone Marrow Transplant 17:709-713
19. Kröger N, Zeller W, Hassan TH, Krüger W, Löliger C, Zander AR (1998) Schedule dependency of granulocyte colony-stimulating factor in peripheral blood progenitor cell mobilization in breast cancer patients (letter). Blood 91:1828-1829
20. Nademanee A, Sniecinski I, Schmidt GM, Dagis AC, O'Donnel NM, Snyder DS, Parker PM, Stein AS, Smith EP, Molina A, Stepan DE, Somlo G, Margolin KA, Woo D, Niland JC, Forman SJ (1994) High-dose therapy followed by autologous peripheral-blood stem cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral blood stem cells. J Clin Oncol 12:2176-2186
21. Sheridan W, Begley CG, To LB, Grigg A, Szer J, Maher D, Green NM, Rowlings PA, McGrath KM, Cebon J, Dyson P, Watson D, Bayly J, DeLuca E, Tomita D, Hoffman E, Morstyn G, Juttner CA, Fox RM (1994) Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 14:105-111
22. Frühauf S, Haas R, Conradt C, Murea S, Witt B, Möhle R, Hunstein W (1995) Peripheral blood progenitor cell (PBPC) counts during steady state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy. Blood 85:2619-2626
23. Klein B, Zhang XG, Lu ZY, Bataille R (1994) Interleukin 6 in human multiple myeloma. Blood 85:863-872
24. Dela Rubia J, Bonanad S, Palau J, Sanz GF, Sanz MA (1994) Rapid progression of multiple myeloma following G-CSF mobilization. Bone Marrow Transplant 14:475-476
25. Hollmig KA, Söhngen D, Kobbe G, Heins M, Schneider P, Heyll A, Schneider W (1996) Interleukin 6 in patients with multiple myeloma stimulated with granulocyte-colony stimulating factor for peripheral blood stem cell separation. Ann Hematol 73 [Suppl 2]: 142 (abstract)